Eight Months of Serological Follow-Up of Anti-SARS-CoV-2 Antibodies in France: A Study among an Adult Population

被引:0
|
作者
Decarreaux, Dorine [1 ,2 ,3 ]
Sevila, Julie [1 ]
Masse, Shirley [1 ]
Capai, Lisandru [1 ]
Fourie, Toscane [3 ]
Villarroel, Paola Mariela Saba [3 ]
Amroun, Abdennour [3 ]
Nurtop, Elif [3 ]
Vareille, Matthieu [1 ]
Blanchon, Thierry [2 ]
de Lamballerie, Xavier [3 ]
Charrel, Remi [3 ]
Falchi, Alessandra [1 ]
机构
[1] Univ Corse Pascal Paoli, Lab Virol, UR7310 Bioscope, F-20250 Corte, France
[2] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM, IPLESP, F-75012 Paris, France
[3] Aix Marseille Univ, Unite Virus Emergents, IHU Mediterranee Infect, INSERM U1207,IRD 190, F-13005 Marseille, France
关键词
COVID-19; seroconversion; long-lasting immunity; antibodies; vaccination; INFECTION; COVID-19;
D O I
10.3390/ijerph192215257
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Uncertainties remain regarding the nature and durability of the humoral immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Aim: This study investigated immunoglobulin G response and neutralizing activity to evaluate the mean antibody concentrations and response duration induced by each vaccination regimen in a French adult population. Methods: A study including blood sampling and questionnaires was carried out from November 2020 to July 2021 with three separate follow-up phases. Spike proteins and neutralizing antibodies were quantified using ELISA and a virus-neutralization test. Results: Overall, 295 participants were included. Seroprevalences were 11.5% (n = 34), 10.5% (n = 31), and 68.1% (n = 201) in phases 1, 2, and 3, respectively. Importantly, 5.8% (n = 17) of participants lost their natural antibodies. Antibody response of participants with only a prior infection was 88.2 BAU/mL, significantly lower than those vaccinated, which was 1909.3 BAU/mL (p = 0.04). Moreover, the antibody response of vaccinated participants with a prior infection was higher (3593.8 BAU/mL) than those vaccinated without prior infection (3402.9 BAU/mL) (p = 0.78). Vaccinated participants with or without prior infection had a higher seroneutralization rate (91.0%) than those unvaccinated with prior infection (65.0%). Conclusion: These results demonstrated that single infection does not confer effective protection against SARS-CoV-2.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Human Milk Antibodies Against SARS-CoV-2: A Longitudinal Follow-Up Study
    Juncker, Hannah G.
    Romijn, M.
    Loth, Veerle N.
    Caniels, Tom G.
    de Groot, Christianne J. M.
    Pajkrt, Dasja
    van Gils, Marit J.
    van Goudoever, Johannes B.
    van Keulen, Britt J.
    JOURNAL OF HUMAN LACTATION, 2021, 37 (03) : 485 - 491
  • [42] Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats
    Stranieri, Angelica
    Lauzi, Stefania
    Giordano, Alessia
    Galimberti, Luigi
    Ratti, Gabriele
    Decaro, Nicola
    Brioschi, Federica
    Lelli, Davide
    Gabba, Silvia
    Amarachi, Ndiana Linda
    Lorusso, Eleonora
    Moreno, Ana
    Trogu, Tiziana
    Paltrinieri, Saverio
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (04) : 2089 - 2095
  • [43] Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
    Tancredi, Stefano
    Chiolero, Arnaud
    Wagner, Cornelia
    Haller, Moa Lina
    Chocano-Bedoya, Patricia
    Ortega, Natalia
    Rodondi, Nicolas
    Kaufmann, Laurent
    Lorthe, Elsa
    Baysson, Helene
    Stringhini, Silvia
    Michel, Gisela
    Ludi, Chantal
    Harju, Erika
    Frank, Irene
    Imboden, Medea
    Witzig, Melissa
    Keidel, Dirk
    Probst-Hensch, Nicole
    Amati, Rebecca
    Albanese, Emiliano
    Corna, Laurie
    Crivelli, Luca
    Vincentini, Julia
    Nussle, Semira Gonseth
    Bochud, Murielle
    D'Acremont, Valerie
    Kohler, Philipp
    Kahlert, Christian R.
    Cusini, Alexia
    Frei, Anja
    Puhan, Milo A.
    Geigges, Marco
    Kaufmann, Marco
    Fehr, Jan
    Cullati, Stephane
    INFECTION, 2023, 51 (05) : 1453 - 1465
  • [44] Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy
    Paduano, Stefania
    Galante, Pasquale
    Berselli, Nausicaa
    Ugolotti, Luca
    Modenese, Alberto
    Poggi, Alessandro
    Malavolti, Marcella
    Turchi, Sara
    Marchesi, Isabella
    Vivoli, Roberto
    Perlini, Paola
    Bellucci, Rossana
    Gobba, Fabriziomaria
    Vinceti, Marco
    Filippini, Tommaso
    Bargellini, Annalisa
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (13)
  • [45] Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study
    Zaballa, Maria-Eugenia
    Perez-Saez, Javier
    de Mestral, Carlos
    Pullen, Nick
    Lamour, Julien
    Turelli, Priscilla
    Raclot, Charlene
    Baysson, Helene
    Pennacchio, Francesco
    Villers, Jennifer
    Duc, Julien
    Richard, Viviane
    Dumont, Roxane
    Semaani, Claire
    Loizeau, Andrea Jutta
    Graindorge, Clement
    Lorthe, Elsa
    Balavoine, Jean-Francois
    Pittet, Didier
    Schibler, Manuel
    Vuilleumier, Nicolas
    Chappuis, Francois
    Kherad, Omar
    Azman, Andrew S.
    Posfay-Barbe, Klara M.
    Kaiser, Laurent
    Trono, Didier
    Stringhini, Silvia
    Guessous, Idris
    LANCET REGIONAL HEALTH-EUROPE, 2023, 24
  • [46] Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients
    Rostamzadeh, Davood
    Mortezagholi, Sahar
    Alinejad, Maedeh
    Jooya, Seyed Reza
    Eskandarian, Maryam
    Metvaei, Alireza
    Vafaei, Sedigheh
    Aboulghasemi, Hasan
    Younesi, Vahid
    Shabani, Mahdi
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2021, 210 (5-6) : 283 - 289
  • [47] Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors
    Arabkhazaeli, Ali
    Maghsudlu, Mahtab
    Mohammadi, Saeed
    Eshghi, Peyman
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2022, 29 (01) : 24 - 30
  • [48] Anti-SARS-CoV-2 antibodies among vaccinated healthcare workers: Repeated cross-sectional study
    Mishra, Sanjeeb Kumar
    Pradhan, Subrat Kumar
    Pati, Sanghamitra
    Panda, Bimal Krushna
    Bhattacharya, Debdutta
    Sahu, Sumanta Kumar
    Kshatri, Jaya Singh
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (05) : 1883 - 1889
  • [49] Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients
    Davood Rostamzadeh
    Sahar Mortezagholi
    Maedeh Alinejad
    Seyed Reza Jooya
    Maryam Eskandarian
    Alireza Metvaei
    Sedigheh Vafaei
    Hasan Aboulghasemi
    Vahid Younesi
    Mahdi Shabani
    Medical Microbiology and Immunology, 2021, 210 : 283 - 289
  • [50] A Study of Factors that Impact the Production of Anti-SARS-CoV-2 Antibodies in Patients with Covid-19
    Hussein, Nawfal R.
    Balatay, Amer
    Mohammad, Ameen M.
    Dhama, Kuldeep
    Rasheed, Narin A.
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2022, 8 (05): : 323 - 326